Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.

Authors :: de Tute RM
Cook G
Cairns DA
Brown JM
Cavenagh J
Ashcroft AJ
Snowden JA
Yong K
Tholouli E
Jenner M
Hockaday A
Drayson MT
Morris TCM
Rawstron AC
Owen RG
Source :: Bone marrow transplantation [Bone Marrow Transplant] 2024 Mar; Vol. 59 (3), pp. 431-434. Date of Electronic Publication: 2024 Jan 09.
Publication Year :: 2024

Subjects :: Humans
Neoplasm Recurrence, Local
Neoplasm, Residual
Stem Cell Transplantation methods
Transplantation, Autologous
Clinical Trials as Topic
Hematopoietic Stem Cell Transplantation methods
Multiple Myeloma therapy

Full Text Access

Tools